These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 37234293)
21. Intrinsic suppression of type I interferon production underlies the therapeutic efficacy of IL-15-producing natural killer cells in B-cell acute lymphoblastic leukemia. Kumar A; Taghi Khani A; Duault C; Aramburo S; Sanchez Ortiz A; Lee SJ; Chan A; McDonald T; Huang M; Lacayo NJ; Sakamoto KM; Yu J; Hurtz C; Carroll M; Tasian SK; Ghoda L; Marcucci G; Gu Z; Rosen ST; Armenian S; Izraeli S; Chen CW; Caligiuri MA; Forman SJ; Maecker HT; Swaminathan S J Immunother Cancer; 2023 May; 11(5):. PubMed ID: 37217248 [TBL] [Abstract][Full Text] [Related]
22. Novel pathological predictive factors for extranodal extension in oral squamous cell carcinoma: a retrospective cohort study based on tumor budding, desmoplastic reaction, tumor-infiltrating lymphocytes, and depth of invasion. Noda Y; Ishida M; Ueno Y; Fujisawa T; Iwai H; Tsuta K BMC Cancer; 2022 Apr; 22(1):402. PubMed ID: 35418058 [TBL] [Abstract][Full Text] [Related]
23. Evaluation of Tumor-associated Tissue Eosinophilia in Different Stages of Oral Squamous Cell Carcinoma using Special Stains: An in vitro Histopathological Study. Vaibhav SL; Priya PL; Sonam CK; Supriya K; Garima Y; Sabeer S; Juvale P; Javir G J Contemp Dent Pract; 2018 May; 19(5):579-586. PubMed ID: 29807970 [TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of tumor infiltrating immune cells in oral squamous cell carcinoma. Fang J; Li X; Ma D; Liu X; Chen Y; Wang Y; Lui VWY; Xia J; Cheng B; Wang Z BMC Cancer; 2017 May; 17(1):375. PubMed ID: 28549420 [TBL] [Abstract][Full Text] [Related]
25. Cetuximab therapy in head and neck cancer: immune modulation with interleukin-12 and other natural killer cell-activating cytokines. Luedke E; Jaime-Ramirez AC; Bhave N; Roda J; Choudhary MM; Kumar B; Teknos TN; Carson WE Surgery; 2012 Sep; 152(3):431-40. PubMed ID: 22770960 [TBL] [Abstract][Full Text] [Related]
26. A study on histological grading systems of oral squamous cell carcinoma and comparison of their efficacy in determining the nature (clinical and histopathological) and prognosis of oral squamous cell carcinoma. Pandya JA; Natarajan S J Cancer Res Ther; 2023 Apr; 19(Supplement):S198-S205. PubMed ID: 37147997 [TBL] [Abstract][Full Text] [Related]
27. The prognostic significance of intratumoral natural killer cells in patients with colorectal carcinoma. Coca S; Perez-Piqueras J; Martinez D; Colmenarejo A; Saez MA; Vallejo C; Martos JA; Moreno M Cancer; 1997 Jun; 79(12):2320-8. PubMed ID: 9191519 [TBL] [Abstract][Full Text] [Related]
28. Evaluation of natural killer cell defense in oral squamous cell carcinoma. Türkseven MR; Oygür T Oral Oncol; 2010 May; 46(5):e34-7. PubMed ID: 20347380 [TBL] [Abstract][Full Text] [Related]
29. Interaction between peritumoral reactivity and histomorphological pattern of lymph node reactivity in oral squamous cell carcinoma: A host immune status indicator. Bhatta A; Rath R; Das SN; Mishra SS; Sethi D J Cancer Res Ther; 2022; 18(1):124-132. PubMed ID: 35381773 [TBL] [Abstract][Full Text] [Related]
30. Histopathological evaluation of minor salivary gland aberrations in oral squamous cell carcinoma. Bhola R; Narwal A; Kamboj M; Devi A; Anand R; Chatterjee S J Cancer Res Ther; 2023; 19(2):299-303. PubMed ID: 37313908 [TBL] [Abstract][Full Text] [Related]
31. Tumor budding is an independent prognostic factor for prediction of lymph node metastasis in oral squamous cell carcinoma. Angadi PV; Patil PV; Hallikeri K; Mallapur MD; Hallikerimath S; Kale AD Int J Surg Pathol; 2015 Apr; 23(2):102-10. PubMed ID: 25559273 [TBL] [Abstract][Full Text] [Related]
32. Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts). Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R Clin Ter; 2006; 157(4):377-86. PubMed ID: 17051976 [TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical expression of budding uninhibited by benzimidazole related 1 in leukoplakia and oral squamous cell carcinoma. Sravya T; Sivaranjani Y; Rao GV J Oral Maxillofac Pathol; 2016; 20(1):71-7. PubMed ID: 27194865 [TBL] [Abstract][Full Text] [Related]
34. IFN-γ production by human natural killer cells in response to HCV-infected hepatoma cells is dependent on accessory cells. Zhang S; Saha B; Kodys K; Szabo G J Hepatol; 2013 Sep; 59(3):442-9. PubMed ID: 23665181 [TBL] [Abstract][Full Text] [Related]
35. A study of salivary lactate dehydrogenase isoenzyme levels in patients with oral leukoplakia and squamous cell carcinoma by gel electrophoresis method. Joshi PS; Golgire S J Oral Maxillofac Pathol; 2014 Sep; 18(Suppl 1):S39-44. PubMed ID: 25364177 [TBL] [Abstract][Full Text] [Related]
37. Monocyte/macrophage-elicited natural killer cell dysfunction in hepatocellular carcinoma is mediated by CD48/2B4 interactions. Wu Y; Kuang DM; Pan WD; Wan YL; Lao XM; Wang D; Li XF; Zheng L Hepatology; 2013 Mar; 57(3):1107-16. PubMed ID: 23225218 [TBL] [Abstract][Full Text] [Related]
38. Heat shock protein 70 and tumor-infiltrating NK cells as prognostic indicators for patients with squamous cell carcinoma of the head and neck after radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG). Stangl S; Tontcheva N; Sievert W; Shevtsov M; Niu M; Schmid TE; Pigorsch S; Combs SE; Haller B; Balermpas P; Rödel F; Rödel C; Fokas E; Krause M; Linge A; Lohaus F; Baumann M; Tinhofer I; Budach V; Stuschke M; Grosu AL; Abdollahi A; Debus J; Belka C; Maihöfer C; Mönnich D; Zips D; Multhoff G Int J Cancer; 2018 May; 142(9):1911-1925. PubMed ID: 29235112 [TBL] [Abstract][Full Text] [Related]
39. Tumour budding evaluated in biopsy specimens is a useful predictor of prognosis in patients with cN0 early stage oral squamous cell carcinoma. Seki M; Sano T; Yokoo S; Oyama T Histopathology; 2017 May; 70(6):869-879. PubMed ID: 27926795 [TBL] [Abstract][Full Text] [Related]
40. A water-soluble derivative of propolis augments the cytotoxic activity of natural killer cells. Takeda K; Nagamatsu K; Okumura K J Ethnopharmacol; 2018 May; 218():51-58. PubMed ID: 29496576 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]